MedLife could tap BVB for EUR 80 mln financing

Private healthcare operator MedLife evaluates the opportunity of an EUR 80 mln financing via the Bucharest Stock Exchange (BVB). Approximately EUR 20 million could be attracted through capital increase and approximately EUR 60 million through bonds issue. The funds that will be attracted will go to the acquisition program and greenfield projects.

The Administration Council MedLife called the general meeting of shareholders for September 13 and has as main objective the approval of several topics on the agenda.

The share capital of the company could be increased by up to RON 650,000, according to one of the points of the shareholders’ agenda.

This increase will take place by issuing up to 2.6 million new shares, in exchange for some contributions in cash and if this increase will be made at maximum authorized level, the social capital will increase from RON 5.02 million to RON 5.67 million.

At the same time, CA MedLife proposes to the General Meeting to approve the issue of some non-guaranteed corporate bonds, with an overall nominal value of maximum RON 274.2 million, which will be offered to investors through a private investment or a public tender.

“In the last years, MedLife kept its leading position on the medical services market, making 16 successful acquisitions and integrations, besides the solid organic growth. We want to take advantage of the opportunities that the market offers us, and as we estimate that next year will take place some transactions, we are preparing for the central role in the market consolidation,” said Mihai Marcu, president and CEO MedLife.